跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,268 条关于
“vorolanib intravitreal insert”
全部
3,268
临床试验
2,744
药物
73
机构
17
资讯
434
12天前
EyePoint's DURAVYU Misses Primary Endpoint in Phase 3 LUGANO Trial for Wet AMD
去年
DURAVYU Shows Promising Results in Phase 2 VERONA Trial for Retinal Diseases
9个月前
Two Novel Therapies Show Promise for Neovascular AMD: Duravyu Insert and Ixo-vec Gene Therapy Demonstrate Safety and Efficacy in Phase 2 Trials
9个月前
Tyrosine Kinase Inhibitors and Gene Therapies Show Promise for Wet AMD Treatment
去年
EyePoint's DURAVYU Shows Promising Results in Phase 2 DME Trial with Extended Treatment Duration
去年
EyePoint Pharmaceuticals Doses First Patient in Phase 3 LUGANO Trial of Duravyu for Wet AMD
去年
EyePoint's DURAVYU Shows Promise in Wet AMD and DME Trials, Anticipates Key Milestones in 2025
2年前
Novel Therapies for Wet AMD Target Reduced Injection Burden and Broader VEGF Inhibition
去年
EyePoint's EYP-1901 Shows Non-Inferiority to Aflibercept in Wet AMD
去年
EyePoint's DURAVYU Shows Promise in Phase 2 DME Trial
第 1 页，共 44 页
上一页
下一页
